JP2008502694A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008502694A5 JP2008502694A5 JP2007516648A JP2007516648A JP2008502694A5 JP 2008502694 A5 JP2008502694 A5 JP 2008502694A5 JP 2007516648 A JP2007516648 A JP 2007516648A JP 2007516648 A JP2007516648 A JP 2007516648A JP 2008502694 A5 JP2008502694 A5 JP 2008502694A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- pharmaceutical composition
- composition according
- optionally substituted
- aryl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 125000000217 alkyl group Chemical group 0.000 claims 15
- 239000008194 pharmaceutical composition Substances 0.000 claims 15
- 229910052739 hydrogen Inorganic materials 0.000 claims 5
- 239000001257 hydrogen Substances 0.000 claims 5
- 125000004356 hydroxy functional group Chemical group O* 0.000 claims 5
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 5
- 125000003545 alkoxy group Chemical group 0.000 claims 4
- 125000003118 aryl group Chemical group 0.000 claims 4
- 150000001875 compounds Chemical class 0.000 claims 4
- 150000002431 hydrogen Chemical class 0.000 claims 4
- 125000003107 substituted aryl group Chemical group 0.000 claims 4
- ZTLSOLUCMQEGEA-UHFFFAOYSA-N bis(3-chloro-4-methylphenyl)boranyl 3-hydroxypyridine-2-carboxylate Chemical compound C1=C(Cl)C(C)=CC=C1B(C=1C=C(Cl)C(C)=CC=1)OC(=O)C1=NC=CC=C1O ZTLSOLUCMQEGEA-UHFFFAOYSA-N 0.000 claims 3
- 229910052736 halogen Inorganic materials 0.000 claims 3
- 150000002367 halogens Chemical class 0.000 claims 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 3
- 125000003282 alkyl amino group Chemical group 0.000 claims 2
- 125000003710 aryl alkyl group Chemical group 0.000 claims 2
- 125000004104 aryloxy group Chemical group 0.000 claims 2
- -1 carboxy, hydroxy Chemical group 0.000 claims 2
- 125000004093 cyano group Chemical group *C#N 0.000 claims 2
- 125000004663 dialkyl amino group Chemical group 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 125000004288 oxazolidin-2-yl group Chemical group [H]N1C([H])([H])C([H])([H])OC1([H])* 0.000 claims 2
- 239000012453 solvate Substances 0.000 claims 2
- 230000003612 virological effect Effects 0.000 claims 2
- 241000711573 Coronaviridae Species 0.000 claims 1
- 241000710781 Flaviviridae Species 0.000 claims 1
- 241000700739 Hepadnaviridae Species 0.000 claims 1
- 241000700586 Herpesviridae Species 0.000 claims 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- 241000712464 Orthomyxoviridae Species 0.000 claims 1
- 241000711504 Paramyxoviridae Species 0.000 claims 1
- 241000709664 Picornaviridae Species 0.000 claims 1
- 241000712907 Retroviridae Species 0.000 claims 1
- 241000700605 Viruses Species 0.000 claims 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims 1
- 125000005115 alkyl carbamoyl group Chemical group 0.000 claims 1
- 125000005196 alkyl carbonyloxy group Chemical group 0.000 claims 1
- 125000005153 alkyl sulfamoyl group Chemical group 0.000 claims 1
- 125000004644 alkyl sulfinyl group Chemical group 0.000 claims 1
- 125000004390 alkyl sulfonyl group Chemical group 0.000 claims 1
- 125000004414 alkyl thio group Chemical group 0.000 claims 1
- 125000004103 aminoalkyl group Chemical group 0.000 claims 1
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 claims 1
- 125000001769 aryl amino group Chemical group 0.000 claims 1
- 125000005129 aryl carbonyl group Chemical group 0.000 claims 1
- 125000005135 aryl sulfinyl group Chemical group 0.000 claims 1
- 125000005110 aryl thio group Chemical group 0.000 claims 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 1
- 125000001309 chloro group Chemical group Cl* 0.000 claims 1
- 125000000753 cycloalkyl group Chemical group 0.000 claims 1
- 125000004986 diarylamino group Chemical group 0.000 claims 1
- 125000005843 halogen group Chemical group 0.000 claims 1
- 125000001072 heteroaryl group Chemical group 0.000 claims 1
- 125000000623 heterocyclic group Chemical group 0.000 claims 1
- 125000005844 heterocyclyloxy group Chemical group 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 1
- 125000006413 ring segment Chemical group 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 125000000547 substituted alkyl group Chemical group 0.000 claims 1
- 125000000446 sulfanediyl group Chemical group *S* 0.000 claims 1
- 125000000020 sulfo group Chemical group O=S(=O)([*])O[H] 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US57941904P | 2004-06-14 | 2004-06-14 | |
| PCT/US2005/020978 WO2006085932A2 (en) | 2004-06-14 | 2005-06-14 | Anti-viral uses of borinic acid complexes |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008502694A JP2008502694A (ja) | 2008-01-31 |
| JP2008502694A5 true JP2008502694A5 (enExample) | 2008-07-31 |
Family
ID=36623539
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007516648A Withdrawn JP2008502694A (ja) | 2004-06-14 | 2005-06-14 | ボリン酸錯体の抗ウイルス使用 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US7393856B2 (enExample) |
| EP (1) | EP1765360B1 (enExample) |
| JP (1) | JP2008502694A (enExample) |
| AT (1) | ATE447960T1 (enExample) |
| BR (1) | BRPI0512049A (enExample) |
| CA (1) | CA2570577A1 (enExample) |
| DE (1) | DE602005017626D1 (enExample) |
| ES (1) | ES2333244T3 (enExample) |
| MX (1) | MXPA06014417A (enExample) |
| PT (1) | PT1765360E (enExample) |
| TW (1) | TW200612967A (enExample) |
| WO (1) | WO2006085932A2 (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2635840A1 (en) * | 2005-12-28 | 2007-07-12 | Anacor Pharmaceuticals, Inc. | Process for manufacturing picolinate borinic esters |
| DK1988779T5 (en) | 2006-02-16 | 2016-10-10 | Anacor Pharmaceuticals Inc | SMALL boron MOLECULES AS ANTI-INFLAMMATORY AGENTS |
| US8853424B2 (en) * | 2008-08-11 | 2014-10-07 | Japan Science And Technology Agency | Protein cross-linking inhibitor |
| US8980544B2 (en) * | 2012-11-27 | 2015-03-17 | The Penn State Research Foundation | Boronic and borinic acid compounds as inhibitors of sulfenic acid-containing proteins |
| US8669207B1 (en) | 2013-01-30 | 2014-03-11 | Dow Agrosciences, Llc. | Compounds and compositions |
| US11039617B2 (en) | 2013-01-30 | 2021-06-22 | Agrofresh Inc. | Large scale methods of uniformly coating packaging surfaces with a volatile antimicrobial to preserve food freshness |
| US10070649B2 (en) | 2013-01-30 | 2018-09-11 | Agrofresh Inc. | Volatile applications against pathogens |
| CA2899317C (en) | 2013-01-30 | 2024-09-10 | Agrofresh Inc. | USE OF BENZOXABOROLES AS VOLATILE ANTIMICROBIAL AGENTS ON MEAT, PLANTS, OR PARTS OF PLANTS |
| US9585396B2 (en) | 2013-01-30 | 2017-03-07 | Agrofresh Inc. | Volatile applications against pathogens |
| KR101756785B1 (ko) | 2015-03-10 | 2017-07-12 | 한국화학연구원 | 4배위 유기 붕소 화합물의 제조방법 |
| WO2017155879A1 (en) | 2016-03-07 | 2017-09-14 | Agrofresh Inc. | Synergistic methods of using benzoxaborole compounds and preservative gases as an antimicrobial for crops |
| MA52337A (fr) | 2017-03-01 | 2021-03-03 | Anacor Pharmaceuticals Inc | Nouveaux analogues d'oxaborole et utilisations de ces derniers |
| TWI883391B (zh) | 2020-02-18 | 2025-05-11 | 美商基利科學股份有限公司 | 抗病毒化合物 |
| EP4204012A1 (en) | 2020-08-31 | 2023-07-05 | Pfizer Inc. | Methods of protecting rna |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU5920400A (en) * | 1999-07-07 | 2001-01-22 | Du Pont Pharmaceuticals Company | Cell-based assay systems for examining hcv ns3 protease activity |
| CN101928295A (zh) * | 2002-12-18 | 2010-12-29 | 安那卡药品公司 | 含有烃基硼酸络合物的抗生素和使用方法 |
-
2005
- 2005-06-14 EP EP05856817A patent/EP1765360B1/en not_active Expired - Lifetime
- 2005-06-14 MX MXPA06014417A patent/MXPA06014417A/es active IP Right Grant
- 2005-06-14 JP JP2007516648A patent/JP2008502694A/ja not_active Withdrawn
- 2005-06-14 TW TW094119708A patent/TW200612967A/zh unknown
- 2005-06-14 WO PCT/US2005/020978 patent/WO2006085932A2/en not_active Ceased
- 2005-06-14 US US11/152,959 patent/US7393856B2/en not_active Expired - Fee Related
- 2005-06-14 BR BRPI0512049-7A patent/BRPI0512049A/pt not_active IP Right Cessation
- 2005-06-14 AT AT05856817T patent/ATE447960T1/de not_active IP Right Cessation
- 2005-06-14 CA CA002570577A patent/CA2570577A1/en not_active Abandoned
- 2005-06-14 ES ES05856817T patent/ES2333244T3/es not_active Expired - Lifetime
- 2005-06-14 DE DE602005017626T patent/DE602005017626D1/de not_active Expired - Lifetime
- 2005-06-14 PT PT05856817T patent/PT1765360E/pt unknown